CASSANDRA ROBERTSON: Open Payments
NPI 1821482399 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$149 in 9 payments from 6 companies in 2025. Trend: 2023 $158 · 2024 $184 · 2025 $149
Food & beverage: $149
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: BREZTRI, TRELEGY ELLIPTA, AUSTEDO XR, INGREZZA, AIRSUPRA, VRAYLAR, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
